> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Clinical obesity has higher mortality than preclinical obesity in three cohorts
- URL: https://www.coios.me/clinical-obesity-has-higher-mortality-than-preclinical/
- Published: 2026-11-15T11:49:55.000Z
- Updated: 2026-11-15T12:11:58.000Z
- Description: Against adults without obesity or organ dysfunction, clinical obesity had a mortality hazard ratio of 1.69 and preclinical obesity 1.19.
- Author: Daniel Ryan
- Tags: Health today, Obesity, diabetes and GLP-1, China, United Kingdom, United States, Spain, #peer-reviewed, #new, #item, #source-2026-11, #score-88

The 2025 Lancet Commission obesity framework was compared with BMI in 844,108 adults from four cohorts. Adding waist circumference and waist-to-height ratio showed BMI alone overestimated obesity in 1.2-3.1% and underestimated it in 5.2-8.6%. Clinical obesity, with organ dysfunction attributed to adiposity, made up 22.7-31.3% of obesity. Between 77.4% and 91.3% with preclinical obesity did not progress to clinical obesity over 10 years. Across Kailuan, UK Biobank and SIDIAP, mortality hazard ratios were 1.69 for clinical and 1.19 for preclinical obesity. Organ dysfunction came from health record codes, and not all 18 indicators were available in every cohort.

*Why it is interesting: Overweight-BMI adults without raised waist measures had lower mortality than normal-BMI adults (hazard ratio 0.88). Adding waist measures to BMI separated higher-risk adults, yet raised obesity prevalence by 3.3-7.4%.*

Source

[Nature, 11 November 2026](https://doi.org/10.1038/s41586-026-11237-5?ref=coios.me)

Paper

Validation of clinical and preclinical obesity across global cohorts

Authors

Pan A, Yang S, Ramos R, Li X, Xie J, Eckel RH et al.

DOI

10.1038/s41586-026-11237-5

Full text

[Open copy](https://www.nature.com/articles/s41586-026-11237-5.pdf?ref=coios.me) (published version, free publisher)

Type

Peer-reviewed article

Design

Pooled prospective cohort analysis of 844,108 adults in four cohorts (China, UK, USA, Spain), \~10-year follow-up for progression and all-cause mortality

Verdict

New finding

Driver

[Obesity, diabetes and GLP-1](https://www.coios.me/d-obesity-diabetes/)

Abstract — the authors' own words, CC BY

In 2025, a Lancet Commission proposed distinguishing clinical obesity, defined by adiposity-related organ dysfunction, from preclinical obesity, defined by excess adiposity with preserved function, and recommended using anthropometric measures beyond body mass index (BMI) to confirm obesity status 1 . Here we report the comparative performance of this framework versus conventional BMI-based classification using prevalence, incidence and mortality data from 844,108 adults across four cohorts in China, the UK, the USA and Spain. Complementing BMI with waist circumference and waist-to-height ratio data showed that BMI alone overestimated obesity in 1.2-3.1% and underestimated it in 5.2-8.6% of participants across cohorts. The combined anthropometric definition increased overall obesity prevalence by 3.3-7.4% relative to BMI-based classification. Clinical obesity accounted for 22.7-31.3% of total obesity, with an overall population prevalence of 5.6-10.9%. A large proportion of individuals (between 77.4% and 91.3%) with preclinical obesity at baseline showed no progression to clinical obesity over 10 years. Increased mortality risk was associated with the combined anthropometric definition of obesity, but not with BMI-only obesity. Clinical obesity was associated with substantially higher all-cause mortality (hazard ratio 1.69, 95% confidence interval 1.64-1.73), whereas preclinical obesity conferred only modest risk (1.19, 1.14-1.24). These findings support the global adoption of the Lancet Commission diagnostic framework to improve obesity care and policy.